A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation

Amitasrigowri S. Murthy, Mitchell D Creinin, Bryna Harwood, Courtney Schreiber

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Hypothesis: Simultaneous administration of mifepristone and misoprostol for medical abortion in women up to 49 days gestation will result in complete abortion in 90% of women within 24 h of treatment. Materials and Methods: Forty women with pregnancies up to 49 days gestation inserted 800 μg vaginal misoprostol in our office immediately after taking mifepristone 200 mg orally. Follow-up visits, which included vaginal ultrasonography, occurred 24±1 h and 2 weeks after treatment. If a gestational sac was still present at the first follow-up visit, the misoprostol dose was repeated. Suction abortion was performed for a viable gestation at the second follow-up visit, presence of a nonviable gestation within 5 weeks of treatment and when clinically indicated. Results: Expulsion occurred in 36/40 (90%, 95% CI 80-99) and 39/40 (98%, 95% CI 93-100) women by the first and second follow-up visits, respectively. One woman who had initially expelled the gestational sac after a single dose of misoprostol later required a suction curettage for an incomplete abortion. Conclusion: Simultaneous administration of mifepristone and vaginal misoprostol is a promising regimen for medical abortion up to 49 days gestation.

Original languageEnglish (US)
Pages (from-to)333-336
Number of pages4
JournalContraception
Volume71
Issue number5
DOIs
StatePublished - May 2005
Externally publishedYes

Fingerprint

Misoprostol
Mifepristone
Pregnancy
Gestational Sac
Vacuum Curettage
Incomplete Abortion
Intravaginal Administration
Suction
Ultrasonography
Therapeutics

Keywords

  • Abortion
  • Medical abortion
  • Mifepristone
  • Misoprostol

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation. / Murthy, Amitasrigowri S.; Creinin, Mitchell D; Harwood, Bryna; Schreiber, Courtney.

In: Contraception, Vol. 71, No. 5, 05.2005, p. 333-336.

Research output: Contribution to journalArticle

Murthy, Amitasrigowri S. ; Creinin, Mitchell D ; Harwood, Bryna ; Schreiber, Courtney. / A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation. In: Contraception. 2005 ; Vol. 71, No. 5. pp. 333-336.
@article{557fdacdd5464f3bbca1b6368ba82585,
title = "A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation",
abstract = "Hypothesis: Simultaneous administration of mifepristone and misoprostol for medical abortion in women up to 49 days gestation will result in complete abortion in 90{\%} of women within 24 h of treatment. Materials and Methods: Forty women with pregnancies up to 49 days gestation inserted 800 μg vaginal misoprostol in our office immediately after taking mifepristone 200 mg orally. Follow-up visits, which included vaginal ultrasonography, occurred 24±1 h and 2 weeks after treatment. If a gestational sac was still present at the first follow-up visit, the misoprostol dose was repeated. Suction abortion was performed for a viable gestation at the second follow-up visit, presence of a nonviable gestation within 5 weeks of treatment and when clinically indicated. Results: Expulsion occurred in 36/40 (90{\%}, 95{\%} CI 80-99) and 39/40 (98{\%}, 95{\%} CI 93-100) women by the first and second follow-up visits, respectively. One woman who had initially expelled the gestational sac after a single dose of misoprostol later required a suction curettage for an incomplete abortion. Conclusion: Simultaneous administration of mifepristone and vaginal misoprostol is a promising regimen for medical abortion up to 49 days gestation.",
keywords = "Abortion, Medical abortion, Mifepristone, Misoprostol",
author = "Murthy, {Amitasrigowri S.} and Creinin, {Mitchell D} and Bryna Harwood and Courtney Schreiber",
year = "2005",
month = "5",
doi = "10.1016/j.contraception.2004.10.006",
language = "English (US)",
volume = "71",
pages = "333--336",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation

AU - Murthy, Amitasrigowri S.

AU - Creinin, Mitchell D

AU - Harwood, Bryna

AU - Schreiber, Courtney

PY - 2005/5

Y1 - 2005/5

N2 - Hypothesis: Simultaneous administration of mifepristone and misoprostol for medical abortion in women up to 49 days gestation will result in complete abortion in 90% of women within 24 h of treatment. Materials and Methods: Forty women with pregnancies up to 49 days gestation inserted 800 μg vaginal misoprostol in our office immediately after taking mifepristone 200 mg orally. Follow-up visits, which included vaginal ultrasonography, occurred 24±1 h and 2 weeks after treatment. If a gestational sac was still present at the first follow-up visit, the misoprostol dose was repeated. Suction abortion was performed for a viable gestation at the second follow-up visit, presence of a nonviable gestation within 5 weeks of treatment and when clinically indicated. Results: Expulsion occurred in 36/40 (90%, 95% CI 80-99) and 39/40 (98%, 95% CI 93-100) women by the first and second follow-up visits, respectively. One woman who had initially expelled the gestational sac after a single dose of misoprostol later required a suction curettage for an incomplete abortion. Conclusion: Simultaneous administration of mifepristone and vaginal misoprostol is a promising regimen for medical abortion up to 49 days gestation.

AB - Hypothesis: Simultaneous administration of mifepristone and misoprostol for medical abortion in women up to 49 days gestation will result in complete abortion in 90% of women within 24 h of treatment. Materials and Methods: Forty women with pregnancies up to 49 days gestation inserted 800 μg vaginal misoprostol in our office immediately after taking mifepristone 200 mg orally. Follow-up visits, which included vaginal ultrasonography, occurred 24±1 h and 2 weeks after treatment. If a gestational sac was still present at the first follow-up visit, the misoprostol dose was repeated. Suction abortion was performed for a viable gestation at the second follow-up visit, presence of a nonviable gestation within 5 weeks of treatment and when clinically indicated. Results: Expulsion occurred in 36/40 (90%, 95% CI 80-99) and 39/40 (98%, 95% CI 93-100) women by the first and second follow-up visits, respectively. One woman who had initially expelled the gestational sac after a single dose of misoprostol later required a suction curettage for an incomplete abortion. Conclusion: Simultaneous administration of mifepristone and vaginal misoprostol is a promising regimen for medical abortion up to 49 days gestation.

KW - Abortion

KW - Medical abortion

KW - Mifepristone

KW - Misoprostol

UR - http://www.scopus.com/inward/record.url?scp=18044386575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18044386575&partnerID=8YFLogxK

U2 - 10.1016/j.contraception.2004.10.006

DO - 10.1016/j.contraception.2004.10.006

M3 - Article

C2 - 15854632

AN - SCOPUS:18044386575

VL - 71

SP - 333

EP - 336

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 5

ER -